Tobacco Use Disorder Periodontitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age greater than 21 years. At least 08 teeth in the mouth, excluding third molars. Periodontitis in stages II to IV and grade C, presence of at least 2 sites with clinical attachment loss bigger or equal 5 mm, and indicated for scaling root planning as a definitive method of therapy. Availability to participate in the consultations, over a period of one year, in the necessary frequencies. Patients who smoke 10 or more cigarettes per day
Exclusion criteria
Exclusion criteria: Patient who has at least one of the following diagnoses: pregnant or breastfeeding, diabetes Mellitus, HIV, or psychomotor disorders. Indication of chemical agents for the control of the supragingival biofilm. Need for antimicrobial prophylaxis for periodontal clinical care or who have received antibiotics within the last 6 months. Receiving periodontal treatment in the last 6 months prior to the study. Use of fixed orthodontic appliance. During the study, the following exclusion criteria will apply: impossibility to follow the consultation regime established by the experimental methodology. Patients who during the time of the research stop smoking. Development of some pathology that may interfere with the periodontal condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical attachment gain will be considered the primary outcome. The level of clinical attachment will be measured, in mm, corresponding to the distance from the cementoenamel junction to the most apical portion that can be probed. Comparisons between the baseline consultation and follow-up periods will be performed. This periodontal parameter will be measured at baseline, after 3, 6 and 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Probing pocket depth reduction will be considered one of the secondary outcomes. The probing pocket depth will be measured, in mm, corresponding to the distance from the gingival margin to the most apical probing portion. Comparisons between the baseline consultation and follow-up periods will be performed. This periodontal parameter will be measured at baseline, after 3, 6 and 12 months.;Reduction of bleeding on probing will be considered one of the secondary outcomes. Bleeding on probing will be considered dichotomously (presence/absence). The reduction of bleeding on probing, between the baseline and follow-up visits, will be considered. This periodontal parameter will be measured at baseline, after 3, 6 and 12 months.;Reduction in the marginal gingival bleeding index will be one of the secondary outcomes. Marginal gingival bleeding will be considered for this measurement. The percentage of reduction in marginal gingival bleeding between the baseline and follow-up visits will be considered. This periodontal parameter will be measured at baseline, after 3, 6 and 12 months.;The reduction in the visible plaque index will be considered as one of the secondary outcomes. The visible plaque index will be measured in a dichotomous way (present/absent). The percentage of visible plaque index reduction between the baseline and follow-up appointments will be considered. This periodontal parameter will be measured at baseline, after 3, 6 and 12 months.;Depth measurements of intrabony defects, measured by means of periapical radiographs, will be measured. The vertical distance from crestal bone of the alveolar bone to the base of the bone defect will be considered in this measurement. These measurements will be performed only on the interproximal surfaces of four previously selected teeth, which will be the four non-adjacent teeth that presented the highest probing pocket depths in the baseline consultation. Radiographic measurements will be performed at the baseline consulta | — |
Countries
BR
Contacts
Universidade Federal de Pelotas